OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis
Yuka Uruma, Toshie Manabe, Yuji Fujikura, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0276774-e0276774
Open Access | Times Cited: 20

Showing 20 citing articles:

Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
Linda Nab, Edward P K Parker, Colm Andrews, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 5, pp. e364-e377
Open Access | Times Cited: 66

COVID-19 Severity and Mortality in Veterans with Chronic Lung Disease
Kristina Crothers, Scott V. Adams, Aaron P. Turner, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 7, pp. 1034-1043
Open Access | Times Cited: 5

Impact of Pulmonary Comorbidities on COVID-19: Acute and Long-Term Evaluations
G Mara, Gheorghe Nini, Coralia Cotoraci
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1446-1446
Open Access

Outcomes among patients with chronic obstructive pulmonary disease after recovery from COVID-19 infection of different severity
Wang Chun Kwok, Chi Hung Chau, Terence Chi Chun Tam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Healthcare utilization trends in adults with asthma or COPD during the first year of COVID-19 pandemic in comparison to pre-pandemic: A population-based study
Tetyana Kendzerska, Michael Pugliese, Douglas G. Manuel, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0316553-e0316553
Open Access

COPD-Related Mortality before and after Mass COVID-19 Vaccination in Northern Italy
Ugo Fedeli, Veronica Casotto, Claudio Barbiellini Amidei, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1392-1392
Open Access | Times Cited: 7

The Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19
Marija Vukoja, Aysun Tekin, Nereida A. Parada, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2390-2398.e7
Closed Access | Times Cited: 2

Asthma and clinical outcomes of COVID-19 in a community setting
Li Jiao, Deborah Bujnowski, Pengfeï Liu, et al.
Public Health (2023) Vol. 226, pp. 84-90
Closed Access | Times Cited: 5

New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS)
Andrea De Vito, Laura Saderi, Agnese Colpani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1

The Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination among Primary Healthcare Patients with Asthma or COPD in Greece: A Cross-Sectional Study
Izolde Bouloukaki, Antonios Christodoulakis, Stavroula Papageorgakopoulou, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 414-414
Open Access | Times Cited: 1

Risk and Protective Factors for COVID‐19 Infection among Pregnant Women with Sickle Cell Trait
Kim Abbegail Tan Aldecoa, Camelia Arsene, Geetha Krishnamoorthy, et al.
Advances in Hematology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1

Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain
Álvaro Serrano-Ortiz, Juan Luis Romero‐Cabrera, Jaime Monserrat Villatoro, et al.
Journal of Epidemiology and Global Health (2024)
Closed Access | Times Cited: 1

Comorbid asthma decreased the risk for COVID-19 mortality in the United Kingdom: Evidence based on a meta-analysis
Liqin Shi, Yadong Wang, Xueya Han, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110365-110365
Open Access | Times Cited: 3

AB2CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units
Virgínia Mara Reis Gomes, Magda Carvalho Pires, Polianna Delfino-Pereira, et al.
Respiratory Medicine (2024) Vol. 227, pp. 107635-107635
Closed Access

Lung function at 1-year follow-up in patients with persistent dyspnea after mild COVID-19 – comparisons with moderate and critical COVID-19
Marta Kisiel, Carl-Johan Neiderud, Emil Ekbom, et al.
Upsala Journal of Medical Sciences (2024) Vol. 129, pp. e10740-e10740
Open Access

Enoxaparin Posology According to Prothrombotic Status and Bleeding Risk in Hospitalized Patients with SARS-CoV-2 Pneumonia
Juan Mora-Delgado, Cristina Lojo-Cruz, Patricia Rubio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 928-928
Open Access | Times Cited: 1

Clinical Outcomes of COVID-19 Infection among Patients with Chronic Obstructive Pulmonary Disease: Findings from the Philippine CORONA Study
Roland Dominic G. Jamora, Albert Jr. B. Albay, Mary Bianca Doreen F. Ditching, et al.
(2023)
Open Access | Times Cited: 1

Clinical Outcomes of COVID-19 Infection among Patients with Chronic Obstructive Pulmonary Disease: Findings from the Philippine CORONA Study
Roland Dominic G. Jamora, Albert B. Albay, Mary Bianca Doreen F. Ditching, et al.
Clinics and Practice (2023) Vol. 13, Iss. 6, pp. 1383-1392
Open Access | Times Cited: 1

Estudio de sobrevida a largo plazo en pacientes adultos con enfermedades respiratorias crónicas atendidos por infección respiratoria aguda por coronavirus SARS-CoV-2
Fernando Saldías P, Denisse Camhi B., Amanda Guzmán Z., et al.
Revista chilena de enfermedades respiratorias (2023) Vol. 39, Iss. 3, pp. 203-215
Open Access

Page 1

Scroll to top